Novo Holdings A/S’s Cogent Biosciences COGT Stock Holding History

Novo Holdings A/S’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-118,360	Closed	-$682K	–	30
2019 Q3	$682K	Hold	118,360	–	–	0.12%	29
2019 Q2	$1.24M	Hold	118,360	–	–	0.17%	28
2019 Q1	$2.08M	Sell	118,360 -23,898	-17%	-$408K	0.31%	22
2018 Q4	$2.5M	Sell	142,258 -24,037	-14%	-$711K	0.35%	22
2018 Q3	$6.85M	Hold	166,295	–	–	0.54%	19
2018 Q2	$9.54M	Hold	166,295	–	–	0.96%	15
2018 Q1	$31.7M	Buy	+166,295	New	+$7.39M	3.97%	5

Other funds holding COGT

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Novo Holdings A/S's COGT Position: Q4 2019 in Review

Novo Holdings A/S sold out of Cogent Biosciences (COGT) in Q4 2019, closing a stake of 118,360 shares — an estimated $682K sold.

Novo Holdings A/S first reported a position in COGT in Q1 2018 and held it in 7 quarters. The position peaked at $31.7M in Q1 2018. 27 funds tracked by Wall St. Rank hold COGT as of Q4 2019.

Novo Holdings A/S reported no remaining Cogent Biosciences position as of Q4 2019 after selling out during the quarter.
Novo Holdings A/S sold 118,360 Cogent Biosciences shares in Q4 2019, an estimated $682K.
Novo Holdings A/S first reported a position in Cogent Biosciences in Q1 2018 and held it in 7 quarters.
Novo Holdings A/S's Cogent Biosciences position peaked at $31.7M in Q1 2018.
27 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2019.

Based on Novo Holdings A/S's 13F filing for Q4 2019, filed 14 Feb 2020.